Point72 Hong Kong LTD Glaukos Corp Transaction History

Point72 Hong Kong LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$34.86 - $63.77 $4,950 - $9,055	142 New	142 $6,000
Q1 2022 May 16, 2022	SELL	$44.33 - $57.82 $31,917 - $41,630	-720 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$40.27 - $56.99 $28,994 - $41,032	720 New	720 $32,000
Q1 2020 May 15, 2020	SELL	$25.53 - $70.14 $41,230 - $113,276	-1,615 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$54.18 - $65.64 $87,500 - $106,008	1,615 New	1,615 $88,000
Q1 2019 May 15, 2019	SELL	$50.75 - $80.54 $88,761 - $140,864	-1,749 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$52.18 - $67.93 $91,262 - $118,809	1,749 New	1,749 $98,000

341

46.8M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.18B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.